Redirect Guidance
The draft guidance of Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics http://www.fda.gov/cder/guidance/6592dft has been replaced by the FINAL guidance: http://www.fda.gov/cder/guidance/7478fnl.pdf
Back
to Top
Back to Guidance Page
PDF requires the free
Adobe Acrobat Reader
Date created: May 15, 2007 |